SACLAC

CAS No. 2248703-42-4

SACLAC( —— )

Catalog No. M37347 CAS No. 2248703-42-4

SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 170 In Stock
10MG 275 In Stock
25MG 550 In Stock
50MG 863 In Stock
100MG 1376 In Stock
200MG 1823 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SACLAC
  • Note
    Research use only, not for human use.
  • Brief Description
    SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
  • Description
    SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | Caspase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2248703-42-4
  • Formula Weight
    377.99
  • Molecular Formula
    C20H40ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(CCl)=O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Polygalacin D

    Polygalacin D shows anti- proliferation, anti-inflammary, and hepatoprotective activities.

  • PBOX 6

    PBOX 6 is a pyrrolo-1,5-benzoxazepine (PBOX) compound exhibiting anticancer and antitumor activity by inhibiting breast cancer cell growth in vitro and selectively inducing apoptosis in leukemia cells through c-Jun NH2 terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.

  • Silvestrol

    Silvestrol is a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in cancer cells through the mitochondrial/apoptosome pathway.